Amrize Ltd Stock 12‑Month Price Target Cut to $52.04, Implies 39% Upside

Amrize Ltd's average stock price target was reduced from $52.37 to $52.04 by 24 analysts, with a range of $40 to $65. This implies a 39% upside from the September 30 closing price. The consensus rating remains 'Buy' among 28 analysts.

Original reporting
Published Oct 1, 2026, 10:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 10:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Amrize Ltd Stock 12‑Month Price Target Cut to $52.04, Implies 39% Upside — source image
Decision brief

The 30-second read

Med
01

Why it matters

The modest target reduction suggests a slight bearish tilt but retains upside expectations.

02

Market read

Minor analyst target adjustment for a micro‑cap; limited immediate market impact.

03

What to watch

Potential upcoming product launches or market catalysts not reflected in the target.

Relevance 6/10Novelty 6/10Timing: immediate

Background

Analyst consensus price target for Amrize Ltd was lowered slightly, maintaining a Buy rating.

Market effects

None

None

None

Counterpoint

The price target cut may be overly cautious given the stock's upside potential.

Key entities

  • Amrize Ltd

    Subject of the price target revision.

Related articles

Med

Amrize Reports Third Quarter 2026 Results

Amrize Ltd (AMRZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Amrize Reports Third Quarter 2026 Results • Revenues up 2.2% to $3,771 million • Net Income grew 3.3% to $558 million • Adjusted EBITDA increased 0.2% to $1,076 million • Margin expansion of 30 basis points in Building Materials • Completed Rapid Redi-Mix acquisition in Dallas-Fo